Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences Shares Outstanding 2006-2020 | GILD

Gilead Sciences shares outstanding history from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Gilead Sciences shares outstanding for the quarter ending March 31, 2020 were 1.270B, a 1.01% decline year-over-year.
  • Gilead Sciences 2019 shares outstanding were 1.277B, a 2.37% decline from 2018.
  • Gilead Sciences 2018 shares outstanding were 1.308B, a 0.83% decline from 2017.
  • Gilead Sciences 2017 shares outstanding were 1.319B, a 2.87% decline from 2016.
  
Gilead Sciences Annual Shares Outstanding
(Millions of Shares)
2019 1,277
2018 1,308
2017 1,319
2016 1,358
2015 1,521
2014 1,647
2013 1,695
2012 1,583
2011 1,580
2010 1,747
2009 1,868
2008 1,918
2007 1,929
2006 1,836
2005 1,897
Gilead Sciences Quarterly Shares Outstanding
(Millions of Shares)
2020-03-31 1,270
2019-12-31 1,277
2019-09-30 1,267
2019-06-30 1,277
2019-03-31 1,283
2018-12-31 1,308
2018-09-30 1,307
2018-06-30 1,308
2018-03-31 1,320
2017-12-31 1,319
2017-09-30 1,319
2017-06-30 1,317
2017-03-31 1,320
2016-12-31 1,358
2016-09-30 1,339
2016-06-30 1,355
2016-03-31 1,412
2015-12-31 1,521
2015-09-30 1,503
2015-06-30 1,540
2015-03-31 1,569
2014-12-31 1,647
2014-09-30 1,637
2014-06-30 1,664
2014-03-31 1,680
2013-12-31 1,695
2013-09-30 1,692
2013-06-30 1,695
2013-03-31 1,665
2012-12-31 1,583
2012-09-30 1,585
2012-06-30 1,561
2012-03-31 1,555
2011-12-31 1,580
2011-09-30 1,563
2011-06-30 1,602
2011-03-31 1,624
2010-12-31 1,747
2010-09-30 1,694
2010-06-30 1,798
2010-03-31 1,857
2009-12-31 1,868
2009-09-30 1,865
2009-06-30 1,869
2009-03-31 1,885
2008-12-31 1,918
2008-09-30 1,921
2008-06-30 1,931
2008-03-31 1,933
2007-12-31 1,929
2007-09-30 1,918
2007-06-30 1,936
2007-03-31 1,925
2006-12-31 1,836
2006-09-30 1,830
2006-06-30 1,905
2006-03-31 1,927
2005-12-31 1,897
2005-09-30 1,904
2005-06-30 1,890
2005-03-31 1,870
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $96.825B $22.449B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $148.880B 16.39
Bristol Myers Squibb (BMY) United States $130.987B 10.94
CSL (CSLLY) Australia $88.639B 0.00
Vertex Pharmaceuticals (VRTX) United States $76.183B 52.38
Regeneron Pharmaceuticals (REGN) United States $70.547B 27.19
Illumina (ILMN) United States $55.309B 56.83
Biogen (BIIB) United States $45.900B 7.86
Seattle Genetics (SGEN) United States $30.021B 0.00
Moderna (MRNA) United States $27.857B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.170B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.975B 10.30
Genmab (GMAB) Denmark $23.063B 19.00
BioMarin Pharmaceutical (BMRN) United States $22.863B 207.26
Incyte (INCY) United States $22.394B 0.00
Genmab (GNMSF) Denmark $21.777B 64.65
BioNTech SE (BNTX) Germany $18.979B 0.00
BeiGene (BGNE) Cayman Islands $18.504B 0.00
Alnylam Pharmaceuticals (ALNY) United States $18.138B 0.00
Exact Sciences (EXAS) United States $13.940B 0.00
Sarepta Therapeutics (SRPT) United States $13.005B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Galapagos (GLPG) Belgium $12.529B 36.85
ARGENX SE-ADR (ARGX) Netherlands $11.952B 0.00
Horizon Therapeutics Public (HZNP) Ireland $10.716B 26.37
QIAGEN (QGEN) Netherlands $10.561B 30.71
Bio-Techne Corp (TECH) United States $10.193B 67.34
Immunomedics (IMMU) United States $9.386B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.373B 0.00
Guardant Health (GH) United States $7.674B 0.00
Exelixis (EXEL) United States $7.298B 25.59
Ascendis Pharma (ASND) Denmark $6.614B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $6.600B 16.42
Repligen (RGEN) United States $6.530B 114.53
Novavax (NVAX) United States $6.374B 0.00
Vir Biotechnology (VIR) United States $5.846B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.633B 121.21
Adaptive Biotechnologies (ADPT) United States $5.488B 0.00
Acceleron Pharma (XLRN) United States $5.295B 0.00
Mirati Therapeutics (MRTX) United States $5.250B 0.00
Emergent Biosolutions (EBS) United States $5.068B 33.22
Ultragenyx Pharmaceutical (RARE) United States $5.028B 0.00
Zai Lab (ZLAB) China $4.978B 0.00
Reata Pharmaceuticals (RETA) United States $4.970B 0.00
MyoKardia (MYOK) United States $4.344B 0.00
Blueprint Medicines (BPMC) United States $4.334B 0.00
Global Blood Therapeutics (GBT) United States $4.286B 0.00
China Biologic Products (CBPO) China $4.223B 23.48
MorphoSys AG (MOR) Germany $4.202B 32.59
Inovio Pharmaceuticals (INO) United States $4.144B 0.00
Momenta Pharmaceuticals (MNTA) United States $4.036B 0.00
Amicus Therapeutics (FOLD) United States $3.875B 0.00
Halozyme Therapeutics (HALO) United States $3.853B 0.00
NeoGenomics (NEO) United States $3.719B 271.61
Bluebird Bio (BLUE) United States $3.497B 0.00
Arena Pharmaceuticals (ARNA) United States $3.381B 0.00
Alkermes (ALKS) Ireland $3.022B 59.50
Deciphera Pharmaceuticals (DCPH) United States $2.930B 0.00
Denali Therapeutics (DNLI) United States $2.725B 0.00
Insmed (INSM) United States $2.682B 0.00
Fate Therapeutics (FATE) United States $2.643B 0.00
Amarin (AMRN) Ireland $2.529B 0.00
PHARMA MAR SA (PHMMF) Spain $2.445B 0.00
Principia Biopharma (PRNB) United States $2.295B 0.00
Twist Bioscience (TWST) United States $2.187B 0.00
Viela Bio (VIE) United States $2.081B 0.00
UniQure (QURE) Netherlands $1.928B 0.00
Ligand Pharmaceuticals (LGND) United States $1.917B 74.64
Eidos Therapeutics (EIDX) United States $1.804B 0.00
I-Mab (IMAB) China $1.786B 0.00
Alector (ALEC) United States $1.778B 0.00
Editas Medicine (EDIT) United States $1.746B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.726B 0.00
Sorrento Therapeutics (SRNE) United States $1.665B 0.00
Cytokineticsorporated (CYTK) United States $1.658B 0.00
Intra-Cellular Therapies (ITCI) United States $1.570B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.561B 0.00
Sangamo Therapeutics (SGMO) United States $1.498B 0.00
Epizyme (EPZM) United States $1.495B 0.00
Adverum Biotechnologies (ADVM) United States $1.479B 0.00
REGENXBIO (RGNX) United States $1.439B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.431B 0.00
Mersana Therapeutics (MRSN) United States $1.423B 0.00
Zymeworks (ZYME) Canada $1.403B 0.00
Revance Therapeutics (RVNC) United States $1.383B 0.00
Zealand Pharma (ZEAL) Denmark $1.371B 0.00
Mesoblast (MESO) Australia $1.337B 0.00
NantKwest (NK) United States $1.332B 0.00
Arvinas (ARVN) United States $1.301B 0.00
Beam Therapeutics (BEAM) United States $1.292B 0.00
NGM Biopharmaceuticals (NGM) United States $1.253B 0.00
Akcea Therapeutics (AKCA) United States $1.238B 0.00
Coherus BioSciences (CHRS) United States $1.235B 8.62
Zealand Pharma (ZLDPF) Denmark $1.232B 0.00
Intellia Therapeutics (NTLA) United States $1.145B 0.00
Alcobra (ARCT) United States $1.137B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.106B 0.00
Arcus Biosciences (RCUS) United States $1.077B 0.00
VBI Vaccines (VBIV) United States $1.040B 0.00
Compugen (CGEN) Israel $0.997B 0.00
Athenex (ATNX) United States $0.982B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.911B 0.00
Retrophin (RTRX) United States $0.881B 0.00
Heska (HSKA) United States $0.870B 0.00
Myriad Genetics (MYGN) United States $0.860B 44.35
Dynavax Technologies (DVAX) United States $0.847B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.821B 0.00
Pharming Group (PHGUF) Netherlands $0.817B 21.75
Intrexon (PGEN) United States $0.773B 0.00
Morphic Holding (MORF) United States $0.758B 0.00
Castle Biosciences (CSTL) United States $0.740B 0.00
Vericel (VCEL) United States $0.734B 135.67
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.721B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.710B 0.00
Cellectis S.A (CLLS) France $0.703B 0.00
Kadmon Holdings (KDMN) United States $0.683B 0.00
Frequency Therapeutics (FREQ) United States $0.675B 0.00
Codexis (CDXS) United States $0.662B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.644B 5.52
Sinovac Biotech (SVA) China $0.640B 20.87
Cue Biopharma (CUE) United States $0.607B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.605B 0.00
Agenus (AGEN) United States $0.604B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
MiMedx (MDXG) United States $0.594B 0.00
AnaptysBio (ANAB) United States $0.565B 0.00
Kala Pharmaceuticals (KALA) United States $0.560B 0.00
Athersys (ATHX) United States $0.554B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.522B 0.00
Cel-Sci (CVM) United States $0.522B 0.00
Syros Pharmaceuticals (SYRS) United States $0.520B 0.00
Anika Therapeutics (ANIK) United States $0.516B 16.59
Prothena (PRTA) Ireland $0.501B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.498B 0.00
UROGEN PHARMA (URGN) United States $0.495B 0.00
Clovis Oncology (CLVS) United States $0.489B 0.00
DBV Technologies S.A (DBVT) France $0.482B 0.00
AC Immune SA (ACIU) Switzerland $0.482B 0.00
MeiraGTx Holdings (MGTX) United States $0.458B 0.00
Scholar Rock Holding (SRRK) United States $0.437B 0.00
Protagonist Therapeutics (PTGX) United States $0.428B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.427B 0.00
BioDelivery Sciences (BDSI) United States $0.427B 22.42
Geron (GERN) United States $0.425B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.421B 0.00
Merus (MRUS) Netherlands $0.411B 0.00
Precision BioSciences (DTIL) United States $0.403B 0.00
Avid Bioservices (CDMO) United States $0.402B 0.00
Puma Biotechnology (PBYI) United States $0.394B 0.00
CytomX Therapeutics (CTMX) United States $0.393B 0.00
Kamada (KMDA) Israel $0.386B 16.04
Albireo Pharma (ALBO) United States $0.367B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.355B 0.00
ANI Pharmaceuticals (ANIP) United States $0.351B 6.83
WAVE Life Sciences (WVE) Singapore $0.345B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.337B 0.00
MannKind (MNKD) United States $0.335B 0.00
Affimed (AFMD) Germany $0.317B 0.00
OSMOTICA PHARM (OSMT) United States $0.317B 0.00
PDL BioPharma (PDLI) United States $0.315B 276.50
ChromaDex (CDXC) United States $0.307B 0.00
Seres Therapeutics (MCRB) United States $0.300B 0.00
Cellular Biomedicine (CBMG) United States $0.295B 0.00
Prometic Life Sciences (LMNL) Canada $0.295B 0.00
Starpharma Holdings (SPHRY) Australia $0.292B 0.00
Spero Therapeutics (SPRO) United States $0.277B 0.00
IBio (IBIO) United States $0.275B 0.00
Pfenex (PFNX) United States $0.270B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.264B 0.00
Menlo Therapeutics (MNLO) United States $0.263B 0.00
Northwest Biotherapeutics (NWBO) United States $0.257B 0.00
NextCure (NXTC) United States $0.250B 0.00
ADMA Biologics Inc (ADMA) United States $0.243B 0.00
Abeona Therapeutics (ABEO) United States $0.237B 0.00
Celldex Therapeutics (CLDX) United States $0.234B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.233B 0.00
Dyadic (DYAI) United States $0.230B 0.00
Verastem (VSTM) United States $0.228B 0.00
IVERIC Bio (ISEE) United States $0.223B 0.00
Fortress Biotech (FBIO) United States $0.223B 0.00
Five Prime Therapeutics (FPRX) United States $0.219B 0.00
Aduro Biotech (ADRO) United States $0.219B 0.00
HOOKIPA Pharma (HOOK) United States $0.215B 0.00
Selecta Biosciences (SELB) United States $0.213B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.210B 3.16
Pluristem Therapeutics (PSTI) Israel $0.209B 0.00
Aptinyx (APTX) United States $0.208B 0.00
Exicure (XCUR) United States $0.205B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.204B 0.00
Sutro Biopharma (STRO) United States $0.203B 0.00
GENFIT S.A (GNFT) France $0.197B 0.00
XOMA (XOMA) United States $0.195B 0.00
POXEL SA FRANCE (PXXLF) France $0.190B 0.00
Liquidia Technologies (LQDA) United States $0.190B 0.00
Strongbridge Biopharma (SBBP) United States $0.184B 0.00
Trevena (TRVN) United States $0.182B 0.00
ARAVIVE, INC (ARAV) United States $0.170B 0.00
Theratechnologies (THTX) Canada $0.169B 0.00
Kindred Biosciences (KIN) United States $0.161B 0.00
TELA Bio (TELA) United States $0.158B 0.00
Aytu Bioscience (AYTU) United States $0.157B 0.00
VolitionRX (VNRX) United States $0.155B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.153B 0.00
Bellus Health (BLU) Canada $0.153B 0.00
Celyad SA (CYAD) Belgium $0.153B 0.00
VTv Therapeutics (VTVT) United States $0.152B 0.00
CorMedix Inc (CRMD) United States $0.151B 0.00
Cerecor (CERC) United States $0.148B 0.00
Cidara Therapeutics (CDTX) United States $0.146B 0.00
Applied Genetic Technologies (AGTC) United States $0.145B 0.00
Gritstone Oncology (GRTS) United States $0.145B 0.00
AquaBounty Technologies (AQB) United States $0.140B 0.00
PHASEBIO PHARMA (PHAS) United States $0.136B 0.00
Biofrontera AG (BFRA) Germany $0.136B 0.00
Cyclerion Therapeutics (CYCN) United States $0.131B 0.00
Orgenesis (ORGS) United States $0.128B 0.00
Enzo Biochem (ENZ) United States $0.126B 0.00
Arbutus Biopharma (ABUS) United States $0.124B 0.00
Oncobiologics (OTLK) United States $0.123B 0.00
Lumos Pharma (LUMO) United States $0.117B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.117B 0.00
Palatin Technologies (PTN) United States $0.116B 2.99
Protalix BioTherapeutics (PLX) Israel $0.112B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.112B 0.00
AIT Therapeutics (XAIR) United States $0.105B 0.00
Eton Pharmaceuticals (ETON) United States $0.105B 0.00
Checkpoint Therapeutics (CKPT) United States $0.093B 0.00
Emmaus Life Sciences (EMMA) United States $0.091B 0.00
Vaccinex (VCNX) United States $0.091B 0.00
Windtree Therapeutics (WINT) United States $0.090B 0.00
Cocrystal Pharma (COCP) United States $0.090B 0.00
Cardiff Oncology (CRDF) United States $0.090B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.089B 0.00
Unum Therapeutics (UMRX) United States $0.089B 0.00
Antibe Therapeutics (ATBPF) Canada $0.087B 0.00
DiaMedica Therapeutics (DMAC) United States $0.083B 0.00
Adocia (ADOCY) France $0.080B 0.00
Organovo Holdings (ONVO) United States $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.075B 0.00
SESEN BIO, INC (SESN) United States $0.074B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.068B 0.00
Catalyst Biosciences (CBIO) United States $0.068B 0.00
Proteostasis Therapeutics (PTI) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.066B 0.00
Happiness Biotech Group (HAPP) China $0.066B 0.00
Stealth BioTherapeutics (MITO) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
Synlogic (SYBX) United States $0.061B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
AnPac Bio-Medical Science (ANPC) China $0.058B 0.00
Ecology Coatings (ABVC) United States $0.057B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.057B 0.00
Soligenix (SNGX) United States $0.052B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
CollPlant Holdings (CLGN) Israel $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.045B 0.00
Signal Genetics (MGEN) United States $0.044B 0.00
Prima BioMed (IMMP) Australia $0.043B 0.00
Curis (CRIS) United States $0.043B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Edesa Biotech (EDSA) Canada $0.042B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
Celsion (CLSN) United States $0.040B 0.00
ATyr Pharma (LIFE) United States $0.039B 0.00
Cleveland BioLabs (CBLI) United States $0.037B 0.00
Pulmatrix (PULM) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Advaxis (ADXS) United States $0.033B 0.00
OvaScience (MLND) United States $0.032B 0.00
Spherix (AIKI) United States $0.029B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Chanticleer Holdings (SONN) United States $0.028B 0.00
Cesca Therapeutics (THMO) United States $0.027B 0.00
IMMURON (IMRN) Australia $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Evogene (EVGN) Israel $0.025B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Prana Biotechnology (ATHE) Australia $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.024B 0.00
FORTE BIOSCIENC (FBRX) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.021B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
BioCardia (BCDA) United States $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
VIVUS (VVUS) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
AEterna Zentaris (AEZS) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00